What is the recommended treatment for a patient with Bell's palsy, particularly within 72 hours of symptom onset and with a potential history of herpes simplex virus infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bell's Palsy Treatment

Prescribe oral corticosteroids immediately—within 72 hours of symptom onset—using prednisolone 50 mg daily for 10 days or prednisone 60 mg daily for 5 days followed by a 5-day taper, as this is the only proven effective treatment that significantly improves facial nerve recovery. 1

Immediate Treatment Algorithm (Within 72 Hours)

First-Line Therapy: Corticosteroids Alone

  • Start oral corticosteroids immediately for all patients ≥16 years old presenting within 72 hours of symptom onset 1
  • Dosing options:
    • Prednisolone 50 mg daily for 10 days (preferred), OR 1
    • Prednisone 60 mg daily for 5 days, then 5-day taper 1
  • Evidence supporting this: 83% recovery at 3 months with prednisolone vs 63.6% with placebo; 94.4% recovery at 9 months vs 81.6% with placebo 1

Optional Add-On: Combination Therapy

  • Consider adding antiviral therapy to corticosteroids (not as monotherapy) within 72 hours if the patient has severe or complete paralysis 1
  • Antiviral options:
    • Valacyclovir 1 g three times daily for 7 days, OR 2
    • Acyclovir 400 mg five times daily for 10 days 1, 2
  • Benefit is modest: 96.5% complete recovery with combination therapy vs 89.7% with steroids alone 1
  • Never prescribe antivirals alone—they are ineffective as monotherapy 1, 2

Critical Timing Consideration

  • Do not initiate corticosteroids beyond 72 hours of symptom onset—there is no evidence of benefit after this window 1

Mandatory Eye Protection (All Patients with Incomplete Eye Closure)

Immediate Implementation

  • Lubricating ophthalmic drops every 1-2 hours while awake 1
  • Ophthalmic ointment at bedtime for sustained moisture 1
  • Eye taping or patching at night with careful instruction to avoid corneal abrasion 1
  • Sunglasses outdoors for protection against wind and particles 1
  • Moisture chambers (polyethylene covers) for severe cases 1

Urgent Ophthalmology Referral Triggers

  • Complete inability to close the eye 1
  • Eye pain, vision changes, redness, or discharge 1
  • Signs of corneal exposure or damage 1

Diagnosis Confirmation (Before Treatment)

Required Clinical Features

  • Rapid onset (<72 hours) of unilateral facial weakness involving the forehead 3, 1
  • Complete hemifacial weakness including inability to raise eyebrow, close eye, or smile symmetrically 3
  • No other neurologic abnormalities—Bell's palsy is a diagnosis of exclusion 3, 1

Red Flags Requiring Imaging (MRI with contrast)

  • Bilateral facial weakness (suggests Guillain-Barré or sarcoidosis, not Bell's palsy) 3, 4
  • Isolated branch paralysis (suggests tumor) 1
  • Other cranial nerve involvement (suggests stroke or tumor) 3, 1
  • Progressive weakness beyond 3 weeks (suggests alternative diagnosis) 1
  • Recurrent paralysis on same side (suggests tumor) 1

Distinguishing from Stroke

  • Stroke spares the forehead (central facial weakness) because of bilateral cortical innervation 3
  • Bell's palsy affects the entire ipsilateral face including forehead 3
  • Stroke typically presents with additional neurologic symptoms: dizziness, dysphagia, diplopia, limb weakness, or speech difficulties 3

Special Populations

Children

  • Better prognosis with up to 90% complete spontaneous recovery 2
  • Corticosteroid benefit is unproven in pediatric patients—no high-quality pediatric trials exist 1
  • Consider treatment on individualized basis with substantial caregiver involvement in shared decision-making 1
  • If treating: prednisolone 1 mg/kg/day (maximum 50-60 mg) for 5 days, then 5-day taper 1

Pregnant Women

  • Treat with oral corticosteroids within 72 hours using the same regimen as non-pregnant adults 1
  • Careful individualized assessment of benefits and risks is recommended 1
  • Eye protection is essential and safe in pregnancy 1

Mandatory Follow-Up and Referral Triggers

At 3 Months

  • Refer to facial nerve specialist if incomplete facial recovery at 3 months 1
  • Approximately 30% of patients experience permanent facial weakness requiring reconstructive evaluation 1

At Any Time Point (Urgent)

  • New or worsening neurologic findings at any point (suggests alternative diagnosis) 1
  • Development of ocular symptoms at any point (risk of permanent corneal damage) 1

Therapies NOT Recommended

Strong Evidence Against

  • Antiviral monotherapy—ineffective and should never be prescribed alone 1, 2
  • Physical therapy—no proven benefit over spontaneous recovery 3, 1
  • Acupuncture—poor quality evidence with indeterminate benefit-harm ratio 3, 1
  • Surgical decompression—rarely indicated except in specialized centers for specific cases 1

Common Pitfalls to Avoid

  • Delaying treatment beyond 72 hours eliminates the proven benefit of corticosteroids 1
  • Prescribing antivirals alone is ineffective and delays appropriate corticosteroid treatment 1
  • Inadequate eye protection can lead to permanent corneal damage, particularly with complete lagophthalmos 1
  • Failing to refer at 3 months delays access to reconstructive options for patients with incomplete recovery 1
  • Missing red flags such as bilateral weakness, other cranial nerve involvement, or progressive symptoms that suggest alternative diagnoses requiring imaging 3, 1
  • Underdosing corticosteroids—ensure adequate dosing with prednisolone 50 mg or prednisone 60 mg, not lower doses 1

Natural History and Prognosis

  • 70-80% of patients recover spontaneously without treatment 5, 6
  • Patients with incomplete paralysis have excellent prognosis with up to 94% recovery 1
  • Most patients begin recovery within 2-3 weeks of symptom onset 1
  • Complete recovery typically occurs within 3-4 months for most patients 1
  • 30% may experience permanent weakness with muscle contractures requiring long-term management 1

References

Guideline

Assessment and Management of Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Bell Palsy: Rapid Evidence Review.

American family physician, 2023

Guideline

Diagnostic Criteria and Exclusions for Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bell's Palsy Diagnosis and Exclusion Criteria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bell's palsy: diagnosis and management.

American family physician, 2007

Related Questions

What is the immediate treatment for a patient diagnosed with Bell's palsy?
What is the initial treatment for a patient diagnosed with Bell's palsy?
What is the treatment for Bell's palsy?
What is the best course of action for an 11-year-old patient with a diagnosis of Bell's palsy who is experiencing burning and tingling sensations in the face 1 week after diagnosis?
What are the clinical presentation and diagnosis of Bell's palsy?
What are the laboratory findings and diagnostic criteria for primary sclerosing cholangitis (PSC) in a patient with a history of inflammatory bowel disease, particularly ulcerative colitis, presenting with symptoms of cholestasis?
When should Austedo (deutetrabenazine) be used versus Ingrezza (valbenazine) for a patient with a movement disorder, such as Huntington's disease or tardive dyskinesia?
What are the typical presentation and treatment options for a patient with a patulous Eustachian tube?
What is the best course of action for an adult or geriatric patient with a history of difficult-to-control hypertension, who is currently experiencing leg swelling while on losartan (angiotensin II receptor antagonist) 50mg and amlodipine (calcium channel blocker), after previously being on losartan and hydrochlorothiazide (HCTZ) (thiazide diuretic) without achieving adequate blood pressure control?
Is there a correlation between breast cancer and cervical cancer in women?
How often does Pluvicto (Lutetium-177 vipivotide tetraxetan) stop working in patients with metastatic castration-resistant prostate cancer?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.